Shares in Novavax are surging 15% in early market trading after the biotech company said that early study data of its COVID-19 vaccine …
Shares in Novavax (NVAX) are currently jumping 42% in pre-market trading after the biotech company said that it has been granted $1.6 billion …
Biotech Novavax (NVAX) has announced that the U.S.
Novavax (NVAX) on Wednesday announced the acquisition of Praha Vaccines to help the late-stage biotech company produce over 1 billion doses of its …
Novavax (NVAX) is now beginning human testing in its Phase 1/2 clinical trial of its coronavirus vaccine candidate, NVX‑CoV2373. Preliminary immunogenicity and safety …
Novavax (NVAX) filed a prospectus to sell up to $250 million of shares of common stock as it prepares to scale up production …
Novavax Inc. (NVAX) jumped 31% after the late-stage biotech company said it will receive $384 million in funding from the Coalition for Epidemic …
COVID-19 has provided opportunity for a number of healthcare companies to take the baton and run with it. One of the names to …
As part of the urgent global race to tackle the coronavirus outbreak, Novavax (NVAX) is due to commence Phase 1 testing for its …
And just like that, Novavax (NVAX) is back in the spotlight. Gaining a whopping 328% since the start of 2020, the healthcare company …
